These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 17278984

  • 1. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
    Tahira Y, Fukuda N, Endo M, Ueno T, Matsuda H, Saito S, Matsumoto K, Mugishima H.
    J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of growth of human gingival fibroblasts by chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1.
    Yusa J, Fukuda N, Sato S, Matsmoto K, Mugishima H, Kamoi K.
    J Periodontol; 2005 Aug; 76(8):1265-74. PubMed ID: 16101357
    [Abstract] [Full Text] [Related]

  • 3. [Effect of perindopril on renal interstitial fibrosis of hypertension in rats].
    Xu H, Tao LJ, Sun M.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):61-4. PubMed ID: 16137008
    [Abstract] [Full Text] [Related]

  • 4. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases.
    Matsuda H, Fukuda N, Ueno T, Tahira Y, Ayame H, Zhang W, Bando T, Sugiyama H, Saito S, Matsumoto K, Mugishima H, Serie K.
    J Am Soc Nephrol; 2006 Feb; 17(2):422-32. PubMed ID: 16371433
    [Abstract] [Full Text] [Related]

  • 5. Ribozyme to human TGF-beta1 mRNA inhibits the proliferation of human vascular smooth muscle cells.
    Su JZ, Fukuda N, Hu WY, Kanmatsuse K.
    Biochem Biophys Res Commun; 2000 Nov 19; 278(2):401-7. PubMed ID: 11097849
    [Abstract] [Full Text] [Related]

  • 6. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T.
    J Pharmacol Exp Ther; 2005 Aug 19; 314(2):514-21. PubMed ID: 15857946
    [Abstract] [Full Text] [Related]

  • 7. [Development of gene therapy for encapsulating peritoneal sclerosis by a chimeric DNA-RNA hammerhead ribozyme targeting TGF-beta1 mRNA].
    Maruyama N, Fukuda N, Okada K, Matsumoto K.
    Nihon Jinzo Gakkai Shi; 2007 Aug 19; 49(2):113-20. PubMed ID: 17375619
    [Abstract] [Full Text] [Related]

  • 8. Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.
    Wong VY, Laping NJ, Nelson AH, Contino LC, Olson BA, Gygielko E, Campbell WG, Barone F, Brooks DP.
    Br J Pharmacol; 2001 Nov 19; 134(5):977-84. PubMed ID: 11682445
    [Abstract] [Full Text] [Related]

  • 9. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
    Krag S, Nyengaard JR, Wogensen L.
    Nephrol Dial Transplant; 2007 Sep 19; 22(9):2485-96. PubMed ID: 17452404
    [Abstract] [Full Text] [Related]

  • 10. GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury?
    Gnudi L, Viberti G, Raij L, Rodriguez V, Burt D, Cortes P, Hartley B, Thomas S, Maestrini S, Gruden G.
    Hypertension; 2003 Jul 19; 42(1):19-24. PubMed ID: 12771048
    [Abstract] [Full Text] [Related]

  • 11. Genetic linkage of albuminuria and renal injury in Dahl salt-sensitive rats on a high-salt diet: comparison with spontaneously hypertensive rats.
    Siegel AK, Kossmehl P, Planert M, Schulz A, Wehland M, Stoll M, Bruijn JA, de Heer E, Kreutz R.
    Physiol Genomics; 2004 Jul 08; 18(2):218-25. PubMed ID: 15161966
    [Abstract] [Full Text] [Related]

  • 12. DNA-RNA chimeric hammerhead ribozyme to transforming growth factor-beta(1) mRNA inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats.
    Teng J, Fukuda N, Hu WY, Nakayama M, Kishioka H, Kanmatsuse K.
    Cardiovasc Res; 2000 Oct 08; 48(1):138-47. PubMed ID: 11033116
    [Abstract] [Full Text] [Related]

  • 13. [Effects of aldosterone on synthesis of fibronectin and expression of transforming growth factor-beta1 mRNA in cultured rat mesangial cells].
    Li XD, Chen XW, Tang DS, Liang D, Liu HF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb 08; 23(2):140-2. PubMed ID: 17286908
    [Abstract] [Full Text] [Related]

  • 14. The interrelationship between TGF-beta1 and nitric oxide is altered in salt-sensitive hypertension.
    Ying WZ, Sanders PW.
    Am J Physiol Renal Physiol; 2003 Nov 08; 285(5):F902-8. PubMed ID: 12865256
    [Abstract] [Full Text] [Related]

  • 15. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1 mRNA inhibits neointima formation in rat carotid artery after balloon injury.
    Ando H, Fukuda N, Kotani M, Yokoyama Si, Kunimoto S, Matsumoto K, Saito S, Kanmatsuse K, Mugishima H.
    Eur J Pharmacol; 2004 Jan 12; 483(2-3):207-14. PubMed ID: 14729108
    [Abstract] [Full Text] [Related]

  • 16. The role of bradykinin B1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP).
    Moniwa N, Agata J, Hagiwara M, Ura N, Shimamoto K.
    Biol Chem; 2006 Feb 12; 387(2):203-9. PubMed ID: 16497153
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
    Watanabe T, Yamamoto T, Ikegaya N, Fujigaki Y, Suzuki H, Togawa A, Fukasawa H, Nagase M, Hishida A.
    J Pathol; 2002 Nov 12; 198(3):397-406. PubMed ID: 12375273
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
    Nishikimi T, Koshikawa S, Ishikawa Y, Akimoto K, Inaba C, Ishimura K, Ono H, Matsuoka H.
    J Hypertens; 2007 May 12; 25(5):1053-63. PubMed ID: 17414670
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional inhibition of progressive renal disease by gene silencing pyrrole-imidazole polyamide targeting of the transforming growth factor-β1 promoter.
    Matsuda H, Fukuda N, Ueno T, Katakawa M, Wang X, Watanabe T, Matsui S, Aoyama T, Saito K, Bando T, Matsumoto Y, Nagase H, Matsumoto K, Sugiyama H.
    Kidney Int; 2011 Jan 12; 79(1):46-56. PubMed ID: 20861821
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
    Yuan J, Jia R, Bao Y.
    J Renin Angiotensin Aldosterone Syst; 2007 Sep 12; 8(3):118-26. PubMed ID: 17907099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.